Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $0.72 in the prior trading day, Neumora Therapeutics Inc (NASDAQ: NMRA) closed at $0.72, up 0.46%. In other words, the price has increased by $0.46 from its previous closing price. On the day, 0.69 million shares were traded.
Ratios:
Our goal is to gain a better understanding of NMRA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.98 and its Current Ratio is at 8.98. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Stifel Downgraded its Buy to Hold on March 07, 2025, whereas the target price for the stock was revised from $6 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’25 when Henry Gosebruch bought 15,000 shares for $1.43 per share.
BERNS PAUL L sold 13,871 shares of NMRA for $23,468 on Feb 18 ’25. The insider now owns 7,405,004 shares after completing the transaction at $1.69 per share. On Feb 18 ’25, another insider, Milligan Michael Lee, who serves as the insider of the company, sold 1,978 shares for $1.69 each. As a result, the insider received 3,351 and left with 22,470 shares of the company.
Stock Price History:
Over the past 52 weeks, NMRA has reached a high of $17.19, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is -9.18%, while the 200-Day Moving Average is calculated to be -89.05%.
Shares Statistics:
A total of 161.75M shares are outstanding, with a floating share count of 65.21M. Insiders hold about 59.69% of the company’s shares, while institutions hold 28.39% stake in the company.
